Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathyBMC cardiovascular disorders, 2024-05, Vol.24 (1), p.255-255 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-024-03924-w ;PMID: 38755595Full text available |
|
2 |
Material Type: Article
|
Ð 53-year-old female with stress-induced cardiomyopathy: Ð clinical caseBʺlgarska kardiologiâ, 2024-05 (1), p.107 [Peer Reviewed Journal]COPYRIGHT 2024 Pensoft Publishers ;ISSN: 1310-7488 ;EISSN: 2683-1015 ;DOI: 10.3897/bgcardio.30.e117188Full text available |
|
3 |
Material Type: Article
|
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic CardiomyopathyJournal of the American Heart Association, 2024-05, Vol.13 (10), p.e033565-e033565 [Peer Reviewed Journal]EISSN: 2047-9980 ;DOI: 10.1161/JAHA.123.033565 ;PMID: 38757491Full text available |
|
4 |
Material Type: Article
|
Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10Channels (Austin, Tex.), 2024-12, Vol.18 (1), p.2355121-2355121 [Peer Reviewed Journal]EISSN: 1933-6969 ;DOI: 10.1080/19336950.2024.2355121 ;PMID: 38762910Full text available |
|
5 |
Material Type: Article
|
Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblastMolecular biology reports, 2024-05, Vol.51 (1), p.661-661 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer Nature B.V. ;ISSN: 0301-4851 ;EISSN: 1573-4978 ;DOI: 10.1007/s11033-024-09594-3 ;PMID: 38758505Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Obstructive hypertrophic cardiomyopathy: a review of new therapiesFuture cardiology, 2023-10, Vol.19 (13), p.661EISSN: 1744-8298 ;PMID: 37933625Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
"successive Delivery Of An Investigational Medicinal Product For The Needs Of A Non-commercial Clinical Trial Entitled "sacubitril/valsartan In The Prevention Of Disease Progression In Patients With Arrhythmogenic Right Ventricular Cardiomyopathy, MulticeMENA Report, 20242022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle BiologyNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
UPDATE: Cytokinetics (CYTK: $59.53) price 5.6% below VWAP; -39c [0.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
UPDATE: Cytokinetics (CYTK: $59.92) price 5.5% below VWAP; reports Loss of $136m; -58c [1.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity GroupNewstex Global Business Blogs, 2024Copyright Newstex May 20, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Lexicon Pharmaceuticals (LXRX: $1.85) sinks 4.6%; -9c [4.6%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Applied Therapeutics (APLT: $4.25) price 5.7% below VWAP; reports Loss of $83.9m; -15c [3.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Mortalidad por Miocarditis Alcohólica en América Latina, 2000-2019Revista Hispanoamericana de Ciencias de la Salud, 2023, Vol.9 (2), p.69-84LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI ;ISSN: 2215-4256Digital Resources/Online E-Resources |
|
15 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)Newstex Global Business Blogs, 2024Copyright Newstex May 20, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Lexeo Therapeutics (LXEO: $13.95) decreases on strong volume; -1c [0.1%] Vol Index 2.8 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
UPDATE: BridgeBio Pharma (BBIO: $30.09) falls 3.4% from 14-day high; -95c [3.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
UPDATE: BridgeBio Pharma (BBIO: $31.05) accelerates rise, up 7.3% in 2 days; +$2.10 [7.3%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Mayo Clinic Minute: Tips to prevent injuries while bikingNews Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Mayo Clinic Health System celebrates grand opening of Mankato hospital expansion and modernizationNews Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |